Melissa Mejias Sinopoli, PA-C Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 3616 Hospital St, Ste A, Pascagoula, MS 39581 Phone: 228-872-6291 Fax: 228-872-7627 |
Mrs. Connie Baker Klotzbach, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2819 Denny Ave, Pascagoula, MS 39581 Phone: 228-818-9620 |
Ms. Baylissa Myles Bridges, P.A. Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 4105 Hospital St, Suite 112b, Pascagoula, MS 39581 Phone: 228-938-0700 Fax: 228-938-0705 |
Allison A Garstecki, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4105 Hospital St, Suite 112b, Pascagoula, MS 39581 Phone: 228-938-0700 Fax: 228-938-0705 |
Mr. Jonathan Bui, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 4105 Hospital Road Suite 103, Pascagoula, MS 39581 Phone: 228-762-9814 |
Katherine Rae Herndon, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2525 Telephone Rd, Pascagoula, MS 39567 Phone: 601-325-8094 |
Carlson D Moss, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: Naval Branch Medical Clinic Pascagoula, Pascagoula, MS 39595 Phone: 228-761-2367 |
Mr. Benjamin P Watts, M.H.S., PA-C Physician Assistant - Surgical Medicare: Accepting Medicare Assignments Practice Location: 3615 Hospital St, Pascagoula, MS 39581 Phone: 228-762-3664 Fax: 228-769-7015 |
Melissa J Thierry, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 3109 Shortcut Rd, Pascagoula, MS 39567 Phone: 228-202-5182 Fax: 228-202-5184 |
Destiny Woods Houchin, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5510 Fax: 228-809-5519 |
News Archive
Even premature babies carry anti-viral antibodies transferred from the mother, researchers at Karolinska Institutet in Sweden report in a paper on maternal antibodies in newborns, published in the journal Nature Medicine.
Metabolic Solutions Development Company, a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has launched a Phase 2a trial for MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes.
A period of rest following a traumatic event can reduce the subsequent development of involuntary 'memory intrusions', one of the hallmark symptoms in post-traumatic stress disorder, a new UCL study has found.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
Researchers from the University of Dundee and the Francis Crick Institute have made a significant discovery about a cellular pathway associated with developmental defects and a myriad of diseases ranging from alopecia to colorectal cancer.
› Verified 7 days ago